Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

SHSE:605016 Stock Report

Market Cap: CN¥5.4b

Shandong Bailong Chuangyuan Bio-Tech Future Growth

Future criteria checks 5/6

Shandong Bailong Chuangyuan Bio-Tech is forecast to grow earnings and revenue by 30.6% and 27.6% per annum respectively. EPS is expected to grow by 30.3% per annum. Return on equity is forecast to be 18.7% in 3 years.

Key information

30.6%

Earnings growth rate

30.3%

EPS growth rate

Food earnings growth22.3%
Revenue growth rate27.6%
Future return on equity18.7%
Analyst coverage

Low

Last updated31 Oct 2024

Recent future growth updates

Recent updates

Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) Solid Profits Have Weak Fundamentals

Nov 06
Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) Solid Profits Have Weak Fundamentals

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.'s (SHSE:605016) Intrinsic Value Is Potentially 78% Above Its Share Price

Oct 14
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.'s (SHSE:605016) Intrinsic Value Is Potentially 78% Above Its Share Price

Many Still Looking Away From Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016)

Sep 29
Many Still Looking Away From Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016)

Here's Why Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Has Caught The Eye Of Investors

Aug 23
Here's Why Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Has Caught The Eye Of Investors

Returns On Capital At Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Have Hit The Brakes

Jun 26
Returns On Capital At Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Have Hit The Brakes

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016) Analysts Are More Bearish Than They Used To Be

May 06
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016) Analysts Are More Bearish Than They Used To Be

Concerns Surrounding Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) Performance

May 03
Concerns Surrounding Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) Performance

If EPS Growth Is Important To You, Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Presents An Opportunity

Mar 27
If EPS Growth Is Important To You, Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Presents An Opportunity

Earnings and Revenue Growth Forecasts

SHSE:605016 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,9524702904063
12/31/20251,5613652183193
12/31/20241,197271-169733
9/30/20241,035234-65217N/A
6/30/2024987221-44191N/A
3/31/2024926202-123201N/A
12/31/2023868193-117195N/A
9/30/2023825174-70187N/A
6/30/2023742163-29191N/A
3/31/2023719154-9167N/A
12/31/2022722151-26150N/A
9/30/2022732147-40141N/A
6/30/2022739131-13143N/A
3/31/2022717128-1095N/A
12/31/20216531044096N/A
9/30/202160599-1551N/A
6/30/202156697-3332N/A
3/31/20215409846119N/A
12/31/20205009637122N/A
9/30/20204799383150N/A
6/30/20204649275138N/A
3/31/202041677-158N/A
12/31/201942183864N/A
12/31/201835665189N/A
12/31/201731164N/A113N/A
12/31/201633665N/A60N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 605016's forecast earnings growth (30.6% per year) is above the savings rate (2.8%).

Earnings vs Market: 605016's earnings (30.6% per year) are forecast to grow faster than the CN market (26.3% per year).

High Growth Earnings: 605016's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 605016's revenue (27.6% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 605016's revenue (27.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 605016's Return on Equity is forecast to be low in 3 years time (18.7%).


Discover growth companies